22
Participants
Start Date
January 31, 2011
Primary Completion Date
January 31, 2014
Study Completion Date
January 31, 2014
ADI-PEG 20 (Arginine deiminase pegylated)
ADI-PEG 20 was administered intramuscularly (IM) at a fixed dose of 320 IU/m\^2 (36.8 mg/m\^2) once weekly for 4 weeks followed by a 1-week follow-up (1 cycle)
Chang Gung Memorial Hospital - LinKou Branch, Taoyuan District
National Cheng Kung University Hospital, Tainan City
National Taiwan University Hospital, Taipei
Memorial Sloan-Kettering Cancer Center, New York
Duke University Medical Center, Durham
University Clinic Saint-Luc, Brussels
Krankenhaus Nordwest, Frankfurt
St. Bartholomew's Hospital, West Smithfield
Lead Sponsor
Collaborators (3)
Memorial Sloan Kettering Cancer Center
OTHER
Duke University
OTHER
St. Bartholomew's Hospital
OTHER
Krankenhaus Nordwest
OTHER
Saint-Luc University Hospital
UNKNOWN
National Taiwan University Hospital
OTHER
National Cheng-Kung University Hospital
OTHER
Chang Gung Memorial Hospital
OTHER
Austin Health
OTHER_GOV
Polaris Group
INDUSTRY
Ludwig Institute for Cancer Research
OTHER